These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12219049)

  • 21. Glycogen storage diseases in Thai patients: Phramongkutklao Hospital experience.
    Kamolsilp M
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S295-301. PubMed ID: 16858972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycogen storage disease type Ib without hypoglycemia.
    Kovacevic A; Ehrlich R; Mayatepek E; Wendel U; Schwahn B
    Mol Genet Metab; 2007 Mar; 90(3):349-50. PubMed ID: 17174133
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nocturnal intragastric glucose infusion in the treatment of glycogenosis 1].
    Pronicka E; Pieniazek D; Rowecka K; Miłoszewska E; Gruszczyńska B; Celińska D; Szymański W; Goncerzewicz M
    Pediatr Pol; 1982; 57(7-8):579-83. PubMed ID: 6963394
    [No Abstract]   [Full Text] [Related]  

  • 24. Antenatal and Intrapartum care of a pregnant woman with glycogen storage disease type 1a.
    Lewis R; Scrutton M; Lee P; Standen GR; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):111-2. PubMed ID: 15596284
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: a potential mechanism that protects against premature atherosclerosis.
    Nguyen AD; Pan CJ; Shieh JJ; Chou JY
    FEBS Lett; 2005 Aug; 579(21):4713-8. PubMed ID: 16098970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of evident atherosclerosis despite multiple risk factors in glycogen storage disease type 1a with hyperadiponectinemia.
    Tamaki M; Tamura Y; Ogihara T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
    Metabolism; 2007 Oct; 56(10):1402-4. PubMed ID: 17884452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High biotinidase activity in type Ia glycogen storage disease.
    Saltik IN; Ozen H; Koçak N; Yüce A; Gürakan F
    Am J Gastroenterol; 2000 Aug; 95(8):2144. PubMed ID: 10950092
    [No Abstract]   [Full Text] [Related]  

  • 28. Glycogen storage disease: new approaches to therapy.
    Crigler JF; Folkman J
    Ciba Found Symp; 1977; (55):331-51. PubMed ID: 95940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.
    Bandsma RH; Prinsen BH; van Der Velden Mde S; Rake JP; Boer T; Smit GP; Reijngoud DJ; Kuipers F
    Pediatr Res; 2008 Jun; 63(6):702-7. PubMed ID: 18520334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The biochemical and pathological study in a long survival case (author's transl)].
    Nomoto M; Nakamura N; Osame M; Igata A; Hasui K; Sato E
    Nihon Naika Gakkai Zasshi; 1981 Sep; 70(9):1283-7. PubMed ID: 6948053
    [No Abstract]   [Full Text] [Related]  

  • 32. Normoglycaemia in Type 1b glycogen storage disease with difficult venous access.
    Hammond S; Krol A; Hampson-Evans D
    Anaesthesia; 2009 Oct; 64(10):1150. PubMed ID: 19735426
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycogen storage disease type Ib without neutropenia generated by a novel splice-site mutation in the glucose-6-phosphate translocase gene.
    Angaroni CJ; Labrune P; Petit F; Sastre D; Capra AE; Dodelson de Kremer R; Argaraña CE
    Mol Genet Metab; 2006 May; 88(1):96-9. PubMed ID: 16490377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
    Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer.
    Ghosh A; Allamarvdasht M; Pan CJ; Sun MS; Mansfield BC; Byrne BJ; Chou JY
    Gene Ther; 2006 Feb; 13(4):321-9. PubMed ID: 16195703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.
    Nguyen AD; Pan CJ; Weinstein DA; Chou JY
    Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density and grip strength in postmenopausal Turkish women with osteoporosis: site specific or systemic?
    Sahin G; Duce MN; Milcan A; Bagis S; Cimen OB; Cimen B; Erdogan C
    Int J Fertil Womens Med; 2002; 47(5):236-9. PubMed ID: 12469710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nation-wide survey on muscle glycogen storage disease (MGSDs) and comparison with our experiences in diagnosis of MGSDs].
    Fukuda T; Sugie H; Ito M; Sugie Y; Saito K; Nishino I; Shimizu T
    Rinsho Shinkeigaku; 2003 May; 43(5):243-8. PubMed ID: 12931628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamic-based computational profiling of cellular regulatory control in hepatocyte metabolism.
    Beard DA; Qian H
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E633-44. PubMed ID: 15507536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of the need for continuous nocturnal feeding in a patient with severe type I glycogen storage disease.
    Greene HL; Parker PH; Slonim AE; Burr IM
    J Pediatr; 1981 Oct; 99(4):602-5. PubMed ID: 6792337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.